ECRI Completes Evaluation of the Pigmented Lesion Assay (PLA), the Foundational Assay for the DermTech Melanoma Test (DMT)
- Health insurance plans and health systems use ECRI’s technology reviews to formulate coverage policies and clinical protocols ... | June 14, 2023